Beckman Coulter has received reports regarding ampicillin and penicillin false resistance with clinical isolates and out-of-range (high) quality control (QC) results on the MICROSTREP Plus 1 (MSTRP+1) and MICROSTREP Plus 2 (MSTRP+2) panel lots included in this recall. Beckman Coulter investigation has confirmed a manufacturing error leading to antimicrobic degredation and the potential for elevated or false resistant results for some antimicrobics (e.g. ampicillin and penicillin) in a portion of the panels within these lots.